Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004135 (
ATM
)
13,001
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Diepoxybutane
(
DEB
) is the most potent active metabolite of the environmental chemical 1,3-butadiene (BD). BD is a known mutagen and human carcinogen and possesses multisystems organ toxicity. We previously reported the elevation of p53 in human TK6 lymphoblasts undergoing
DEB
-induced apoptosis. In this study, we have characterized the
DEB
-induced p53 accumulation and investigated the mechanisms by which
DEB
regulates this p53 accumulation. The elevation of p53 levels in
DEB
-exposed TK6 lymphoblasts and human embryonic lung (HEL) human fibroblasts was found to be largely due to the stabilization of the p53 protein.
DEB
increased the acetylation of p53 at lys-382, dramatically reduced complex formation between p53 and its regulator protein mdm2 and induced the phosphorylation of p53 at serines 15, 20, 37, 46, and 392 in human lymphoblasts. A dramatic increase in phosphorylation of p53 at serine 15 in correlation to total p53 levels was observed in
DEB
-exposed
Ataxia Telangiectasia
Mutated (ATM) proficient human lymphoblasts as compared to
DEB
-exposed ATM-deficient human lymphoblasts; this implicates the ATM kinase in the elevation of p53 levels in
DEB
-exposed cells. Collectively, these findings explain for the first time the mechanism by which p53 accumulates in
DEB
-exposed cells and contributes to the understanding of the molecular toxicity of
DEB
and BD.
...
PMID:Mechanism of diepoxybutane-induced p53 regulation in human cells. 2002 60